Community Mental Health Journal

, Volume 41, Issue 1, pp 51–66 | Cite as

A Psychoeducational Program for Children with ADHD or Depression and their Families: Results from the CMAP Feasibility Study

  • Molly A. Lopez
  • Marcia G. Toprac
  • M. Lynn Crismon
  • Christine Boemer
  • Jennifer Baumgartner
Article

Abstract

For children and adolescents with behavioral and emotional disorders and their families, education about their disorders and the treatments is an essential component of a comprehensive approach to their care. Education can encourage active participation in treatment, enhance adherence to treatment regimens, and provide patients and families with important coping skills. Thus, the Children’s Medication Algorithm Project (CMAP) incorporated a psychoeducational program into the medication algorithm created to improve treatment of children with ADHD and/or depression in the Texas public mental health sector. This article describes the process by which a comprehensive educational program was developed in partnership with parents and advocates. The final program is described, as well as a pilot study to examine the feasibility of implementation in four community clinics.

Keywords

pshycoeducation education major depressive disorder attention deficit hyperactivity disorder Children’s Medication Algorithm Project treatment algorithm 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baumgartner, J. L., Crismon, M. L., & Lopez, M. A. (2002, June). Evaluation of a Patient and Family Education Program for Children and Adolescents with Attention Deficit Hyperactivity Disorder. Poster presented at the 42nd annual meeting of the New Clinical Drug Evaluation Unit (NCDEU) program of NIMH, Boca Raton, FL.Google Scholar
  2. Beardslee, W. R., Gladstone, T. R., Wright, E. J., Cooper, A. B. 2003A family-based approach to the prevention of depressive symptoms in children at risk: Evidence of parental and child changePediatrics112119131Google Scholar
  3. Dixon, L., McFarlane, W. R., Lefley, H., Lucksted, A., Cohen, M., Falloon, I., Mueser, K., Miklowitz, D., Solomon, P., Sondheimer, D. 2001Evidence-based practices for services to families of people with psychiatric disabilitiesPsychiatric Services52903910PubMedGoogle Scholar
  4. Emslie, GJ, Hughes, CW, Crismon, ML, Lopez, MA, Pliszha, SR, Toprac, MG, Boemer, C 2004A feasibility study of the childhood depression medication algorithm: The Texas children’s algorithm project (CMAP)Journal of The American Academy of Child and Adolescent Psychiatry43519527PubMedGoogle Scholar
  5. Emslie, GJ, Rush, AJ, Weinberg, WA, Kowatch, RA, Hughes, CW, Carmody, T, Rintelmann, J 1997A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depressionArchives of General Psychiatry5410311037PubMedGoogle Scholar
  6. Firestone, P. 1982Factors associated with children’s adherence to stimulant medicationsAmerican Journal of Orthopsychiatry52447457PubMedCrossRefGoogle Scholar
  7. Greenhill, L. L., Abikoff, H. B., Arnold, L. E., Cantwell, D. P., Conners, C. K., Elliott, G., Hechtman, L., Hoza, S. P., Jensen, B, March, PS, NewCorn, JS, Pelham, W, Severe, E, Swanson, JB, Vitiello, B, Wells, K 1996Medication treatment strategies in the MTA study: Relevance to clinicians and researchersJournal of the American Academy of Child and Adolescent Psychiatry3513041313PubMedGoogle Scholar
  8. Keller, M. B., Ryan, N. D., Strober, M., Klein, R. G., Kutcher, S. P., Birmaher, B., Hagino, O. R., Koplewicz, H., Carlson, G. A., Clarke, G. N., Emslie, G. J., Feinberg, D., Geller, B., Kusumakar, V., Papetheodorou, G., Sack, W. H., Sweeney, M., Wagner, K. D., Weller, E. B., Wintersa, N. C., Oakes, R., McCafferty, J. P. 2001Efficaffcy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trialJournal of the American Academy of Child & Adolescent Psychiatry40762772Google Scholar
  9. Kemp, R., Hayward, P, Applewhaite, G, Everitt, B, David, A 1996Compliance therapy in psychotic patients: Randomised controlled trialBritish Medical Journal312345349PubMedGoogle Scholar
  10. The MTA Cooperative Group1999Moderators and mediators of treatment response for children with Attention-Deficit/Hyperactivity DisorderArchives of General Psychiatry5610881096Google Scholar
  11. Pliszka, S. R., Lopez, M., Crismon, M. L., Toprac, M., Hughes, C. W., Emslie, G. J., Boemer, C. 2003A feasibility study of the Children’s Medication Algorithm Project (CMAP) algorithm for the treatment of ADHDJournal of the American Academy of Child and Adolescent Psychiatry42279287PubMedGoogle Scholar
  12. Rouse, L. W., MacCabe, N., & Toprac, M. G. (1995). Measuring satisfaction with community-based services for children with severe emotional disturbances. In Proceedings of the 8th Annual Research Conference A System of Care for Children’s Mental Health, 95–96. Google Scholar
  13. Rund, B. R., Moe, L., Sollien, T., Fjell, A., Borchgrevink, T., Hallert, M., Naess, P. O. 1994The Psychosis Project: Outcome and cost-effectiveness of a psychoeducational treatment programme for schizophrenic adolescentsActa Psyciatrica Scandinavica89211218Google Scholar
  14. Seltzer, A., Roncari, I, Garfinkel, P 1980Effect of patient education on medication complianceCanadian Journal of Psychiatry25638645Google Scholar
  15. Sleator, E.K, Ullman, RK, Neuman, A 1992How do hyperactive children feel about taking stimulants and will they tell the doctorClinical Pediatrics21474479Google Scholar
  16. Spencer T. Biederman, J, Wilens, T, Harding, M., O’Donnell, D., Griffin, S. 1996Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycleJournal of the American Academy of Child and Adolescent Psychiatry35409432Google Scholar
  17. Stine, J. J. 1994Psychosocial and psychodynamic issues affecting non-compliance with psychostimulant treatmentJournal of Child and Adolescent Psychopharmacology47586CrossRefGoogle Scholar
  18. Strober, M., Antonio, M., Schmidt-Lackner, S., Pataki, C, Freeman, R, Rigali, J, Rao, U 1999The pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controlsJournal of Clinical Psychiatry60164169PubMedGoogle Scholar
  19. Toprac, M. G., Rush, A. J., Conner, T. M., Crismon, M. L., Dees, M., Hopkins, C., Rowe, V., Shon, S. P. 2000The Texas Medication Algorithm Project Patient and Family Education Program: A consumer-guided initiativeJournal of Clinical Psychiatry61477486PubMedGoogle Scholar
  20. Unützer, J, Rubenstein, L, Katon, WJ, Tang, L, Duan, N, Lagomasino, IT, Wells, KB 2001Two-year effects of quality improvement programs on medication management for depressionArchives of General Psychiatry58935942PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • Molly A. Lopez
    • 1
    • 2
  • Marcia G. Toprac
    • 3
  • M. Lynn Crismon
    • 1
  • Christine Boemer
    • 4
  • Jennifer Baumgartner
    • 5
  1. 1.Texas Department of Mental Health and Mental RetardationThe University of TexasAustin
  2. 2.Texas Department of State Health ServicesAustinUSA
  3. 3.Texas Department of Mental Health and Mental RetardationUSA
  4. 4.Southwestern Medical CenterThe University of TexasUSA
  5. 5.Children’s Medical Center, Southwestern Medical CenterThe University of TexasUSA

Personalised recommendations